CIMAZ, ROLANDO
 Distribuzione geografica
Continente #
NA - Nord America 29.723
EU - Europa 17.256
AS - Asia 11.513
SA - Sud America 1.814
Continente sconosciuto - Info sul continente non disponibili 616
AF - Africa 441
OC - Oceania 280
Totale 61.643
Nazione #
US - Stati Uniti d'America 29.271
RU - Federazione Russa 5.976
IT - Italia 4.175
SG - Singapore 3.506
CN - Cina 2.169
HK - Hong Kong 1.874
IE - Irlanda 1.678
PL - Polonia 1.587
BR - Brasile 1.474
VN - Vietnam 1.381
SE - Svezia 1.357
KR - Corea 1.083
FR - Francia 619
FI - Finlandia 572
DE - Germania 432
IN - India 340
GB - Regno Unito 335
TR - Turchia 288
AU - Australia 278
CA - Canada 258
UA - Ucraina 180
JP - Giappone 169
AR - Argentina 136
JO - Giordania 131
CI - Costa d'Avorio 128
ES - Italia 112
BD - Bangladesh 105
ID - Indonesia 92
IQ - Iraq 90
MX - Messico 83
NG - Nigeria 68
ZA - Sudafrica 65
CH - Svizzera 55
EC - Ecuador 54
NL - Olanda 54
PK - Pakistan 38
MA - Marocco 37
VE - Venezuela 35
EG - Egitto 34
CO - Colombia 29
SA - Arabia Saudita 29
CL - Cile 27
AZ - Azerbaigian 24
PH - Filippine 23
UZ - Uzbekistan 22
AT - Austria 21
JM - Giamaica 19
PY - Paraguay 19
TN - Tunisia 19
BE - Belgio 17
SC - Seychelles 17
KE - Kenya 16
TH - Thailandia 16
AE - Emirati Arabi Uniti 14
BO - Bolivia 14
CR - Costa Rica 14
DZ - Algeria 13
PE - Perù 13
HN - Honduras 12
IR - Iran 12
KZ - Kazakistan 12
LT - Lituania 12
UY - Uruguay 12
DO - Repubblica Dominicana 11
MY - Malesia 11
BG - Bulgaria 10
GT - Guatemala 10
OM - Oman 10
MU - Mauritius 9
RO - Romania 9
SV - El Salvador 9
TW - Taiwan 9
BH - Bahrain 8
CZ - Repubblica Ceca 8
NP - Nepal 8
TT - Trinidad e Tobago 8
IL - Israele 7
PR - Porto Rico 7
AL - Albania 6
ET - Etiopia 6
LB - Libano 6
PT - Portogallo 6
SN - Senegal 6
BJ - Benin 5
KH - Cambogia 5
LV - Lettonia 5
PS - Palestinian Territory 5
RS - Serbia 5
BN - Brunei Darussalam 4
HU - Ungheria 4
KG - Kirghizistan 4
NI - Nicaragua 4
NO - Norvegia 4
PA - Panama 4
AO - Angola 3
BB - Barbados 3
BS - Bahamas 3
BY - Bielorussia 3
CG - Congo 3
CM - Camerun 3
Totale 60.976
Città #
Santa Clara 4.300
Ashburn 3.201
Fairfield 3.160
Singapore 2.429
Chandler 1.690
Dublin 1.675
Warsaw 1.582
Hong Kong 1.437
Woodbridge 1.390
Cambridge 1.302
Seattle 1.270
Houston 1.129
Seoul 1.072
Wilmington 1.033
Milan 955
Altamura 788
Lawrence 721
Beijing 665
San Jose 651
Princeton 645
The Dalles 481
Ann Arbor 450
Ho Chi Minh City 432
Lauterbourg 417
Boston 406
Los Angeles 389
Rome 387
Jacksonville 341
Dallas 337
Buffalo 336
Hanoi 324
Melbourne 262
Moscow 251
Izmir 239
New York 225
Boardman 219
Medford 215
Mumbai 213
Clifton 210
San Diego 184
Tokyo 154
Florence 139
Abidjan 128
Hefei 120
Falls Church 112
São Paulo 110
Helsinki 101
Shanghai 100
Council Bluffs 93
Munich 93
Turin 91
London 89
Naples 88
Figino 86
Norwalk 82
Barcelona 80
Redondo Beach 79
Toronto 74
Frankfurt am Main 67
Bologna 65
Abuja 64
Paris 62
Da Nang 60
Guangzhou 60
Haiphong 60
Miano 58
Bern 52
Palermo 51
Turku 50
Hillsboro 49
Jakarta 45
Yubileyny 45
Chicago 44
Andover 43
Kent 42
Orem 42
Tianjin 41
Genoa 39
Dong Ket 38
Rio de Janeiro 38
Bari 37
Montreal 36
Pune 36
Belo Horizonte 35
Verona 35
Philadelphia 33
Baghdad 31
Brooklyn 29
Curitiba 29
Johannesburg 29
Brasília 28
Amman 27
Brescia 27
Phoenix 26
Denver 25
Columbus 24
Atlanta 23
Porto Alegre 23
Venice 23
Catania 22
Totale 40.925
Nome #
Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients 352
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 315
Th1-induced CD106 expression mediates leukocytes adhesion on synovial fibroblasts from juvenile idiopathic arthritis patients 309
Alteration of Fecal Microbiota Profiles in Juvenile Idiopathic Arthritis. Associations with HLA-B27 Allele and Disease Status. 304
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 298
Managing pediatric osteoporosis 278
The intestinal microbiota in enthesitis-related arthitis 276
Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting 268
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. 265
Common symptoms for a rare disease in a girl with sarcoidosis: a case report 262
Distinctive features of classic and non-classic (Th17-derived) human Th1 cells. 257
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept 255
Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion. 248
Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies 244
Anti-adalimumab antibodies in a cohort of patients with juvenile idiopathic arthritis: incidence and clinical correlations 243
T cell subpopulations in juvenile idiopathic arthritis and their modifications after biotherapies 241
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-alpha therapy in childhood chronic uveitis. 237
Disease activity assessment in childhood vasculitis: development and preliminary validation of the Paediatric Vasculitis Activity Score (PVAS). 234
Immunosuppressive Activity of Abatacept on Circulating T Helper Lymphocytes from Juvenile Idiopathic Arthritis Patients 229
Anti-inflammatory and immunosuppressive drugs and reproduction. 227
Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosa 224
Musculin inhibits human T helper 17 cell response to interleukin 2 by controlling STAT5B activity 221
Does switching anti-TNFα biologic agents represent an effective option in childhood chronic uveitis: The evidence from a systematic review and meta-analysis approach. 216
Demethylation of the RORC2 and IL17A in Human CD4+ T Lymphocytes Defines Th17 Origin of Nonclassic Th1 Cells. 216
Identification of autoantibodies against inner ear antigens in a cohort of children with idiopathic sensorineural hearing loss. 214
Kawasaki disease: an epidemiological study in central Italy 213
Anticorpi anti-istone: È sempre lupus indotto da farmaci? 213
Congenital heart block and immune mediated sensorineural hearing loss: possible cross reactivity of immune response 209
Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. 207
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin. 206
Extracoronary echocardiographic findings as predictors of coronary artery lesions in the initial phase of Kawasaki disease. 205
Mycophenolate mofetil as induction and long-term maintaining treatment in childhood: Primary angiitis of the central nervous system 202
Detection of anti-adalimumab antibodies in a RA responsive cohort of patients using three different techniques 201
Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium 199
Describing Kawasaki shock syndrome: results from a retrospective study and literature review 196
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. 195
Eomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammation 194
Kawasaki disease in infants less than one year of age: An Italian cohort from a single center 193
The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: Clinical manifestations and long-term follow-up. 192
Difficult-To-Treat Juvenile Idiopathic Arthritis: Current and Future Options 190
Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome 190
Surface plasmon resonance-based methodology for anti-adalimumab antibody identification and kinetic characterization 189
Idiopathic congenital atrophoderma of Pasini and Pierini 187
Clonally expanded PD-1-expressing T cells are enriched in synovial fluid of juvenile idiopathic arthritis patients 186
Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. 186
Kawasaki disease in Sicily: clinical description and markers of disease severity. 185
Psoriatic juvenile idiopathic arthritis associated with uveitis: a case report. 185
Atypical presentation of anti-N-methyl-D-aspartate receptor encephalitis: Two case reports 185
Common variable immunodeficiency presenting as sarcoidosis in a 9-year-old child 185
Correction to: The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 183
Methotrexate in juvenile chronic arthritis. 182
Comparing ultraviolet light A photo(chemo)therapy with Methotrexate protocol in childhood localized scleroderma: Evidence from systematic review and meta-analysis approach 182
Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. 181
Pediatric Osteoporosis: Diagnosis and Treatment Considerations 180
Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: An international collaboration 179
Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. 178
Th17 and Th1 lymphocytes in oligoarticular juvenile idiopathic arthritis 178
A 10-year follow-up of alendronate-treated young patients 178
Joint pain management in children and adolescents 177
Inflammatory morphea presenting as a hemifacial acquired port-wine stain 177
Epidemiology of Kawasaki disease in Italy: surveillance from national hospitalization records 176
Anakinra treatment in drug-resistant Behcet's disease: a case series. 176
Lack of association between the HLA-DRB1 locus and post-streptococcal reactive arthritis and acute rheumatic fever in italian children 175
Treating juvenile idiopathic arthritis to target: recommendations of an international task force 175
The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) 174
Systemic Lupus Erythematosus and Bullous Pemphigoid with Dramatic Response to Dapsone 173
Childhood uveitis 173
Biological treatments in behçet's disease: Beyond anti-TNF therapy 173
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF- α Receptor - Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network 171
Evidence of a Transient Nature of the th17 Phenotype of cd4+cd161+t Cells in the Synovial Fluid From Patients with Juvenile Idiopathic Arthritis 169
Canakinumab for the treatment of TNF-receptor associated periodic syndrome 169
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis 168
Idiopathic calcinosis in a paediatric patient 167
Association of low bone mass with vitamin d receptor gene and calcitonin receptor gene polymorphisms in juvenile idiopathic arthritis. 167
Bone mass predictors in a large cohort of children with juvenile idiopathic arthritis (JIA) 167
Recurrent Pericarditis In Children and Adolescents: Etiology, Presentation, Therapies, and Outcomes In a Multicenter Retrospective Cohort Of 100 Patients. 166
AB1025 Chronic Recurrent Multifocal Osteomyelitis (CRMO): The Importance of an Accurate Differential Diagnosis 166
Mucopolysaccharidoses. 164
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). 163
Clinical features and outcome of Cogan syndrome. 163
Anti-TNF agents for the treatment of JIA-related Refractory Uveitis: 2010 UPDATE from the Italian Registry 163
CD4+CD161+cells with Th1 or Th17/Th1 profile accumulate in the synovial fluid of patients with oligo- and polyarticular juvenile idiopathic arthritis 162
Flares after withdrawal of biologic therapies in juvenile idiopathic arthritis: Clinical and laboratory correlates of remission duration 162
Partial Rescue of Biochemical Parameters After Hematopoietic Stem Cell Transplantation in a Patient with Prolidase Deficiency Due to Two Novel PEPD Mutations. 162
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. 162
How advances in personalized medicine will change rheumatology 161
Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis 161
Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach. 160
Successful treatment with canakinumab of a paediatric patient with resistant Behçet's disease 160
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: Our experience and review of the literature. 159
Bone status evaluation with calcaneal ultrasound in children with chronic rheumatic diseases. A one year followup study. 158
Clinical and Therapeutic Features of 312 Patients with Macrophage Activation Syndrome Enrolled in a Multinational Survey 157
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 157
A boy with bizarre hands mimicking an inflammatory chronic disease. 157
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Uveitis 157
Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome. 156
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects 156
Antigen-driven PD-1+TOX+BHLHE40+ and PD-1+TOX+EOMES+ T lymphocytes regulate juvenile idiopathic arthritis in situ 156
Distal extremity pain as a presenting feature of Fabry's disease. 155
Sarcoidosi pediatrica: Esiste davvero? 155
Totale 19.672
Categoria #
all - tutte 183.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 183.961


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.892 0 333 234 160 87 129 92 254 151 89 327 1.036
2022/20237.742 955 1.820 258 524 539 1.439 846 351 587 33 257 133
2023/20242.103 101 342 515 132 129 323 63 287 42 59 69 41
2024/202514.892 727 1.837 1.097 2.369 4.172 1.356 246 803 1.050 388 470 377
2025/202618.562 1.634 2.514 1.156 1.366 1.836 811 2.454 1.070 1.176 987 339 3.219
2026/2027582 553 29 0 0 0 0 0 0 0 0 0 0
Totale 61.643